Rehabiliation of Lower Extremity Injury Patients Using a Weight Bearing Indicator
Project Number1R41AR053407-01
Contact PI/Project LeaderWALCZYK, DANIEL FRANCIS
Awardee OrganizationTEAK INDUSTRIES, INC.
Description
Abstract Text
DESCRIPTION (provided by applicant): The main objective of this Phase I STTR research and development effort is to test the clinical efficacy of a newly patented biomedical device, called a Snap Dome Weight Bearing Indicator (WBI), which is intended to provide a simple, effective, noninvasive and inexpensive device for patients with lower extremity injuries to self-monitor their weight bearing status as required by their physical rehabilitation program. The Snap Dome WBI was co-invented by the PI in 1998 and patented by Rensselaer Polytechnic Institute in 2002 [Walczyk et al.,2002]. Teak Industries in currently negotiating an exclusive rights licensing agreement with RPI. The WBI device is not yet a commercially viable product. The specific aims of this proposed 12-month STTR Phase I research project are to demonstrate the clinical efficacy of this product through a Phase I clinical trial at medical facilities in Albany, NY and Salem, NH. What will be demonstrated is: (1) how simple and inexpensive the Snap Dome WBI is to manufacture, (2) the easy integration of the WBI insert with various medical appliances that can be customized for each patient, (3) that the load transferred to the patient's limb is as expected, and (4) by using this product the mean number of days of hospital stay and rehabilitation can be reduced. If the Snap Dome WBI is shown to be effective, it will: -provide medical professionals (orthopedists, podiatrists, physical therapists) with an important, yet inexpensive tool to ensure that their patients comply with a prescribed physical rehabilitation program.-self-empower patients with an effective means to self-monitor their partial weight bearing status, and-drive down medical costs by reducing the occurrence of re-injury by a patient during rehabilitation.
National Institute of Arthritis and Musculoskeletal and Skin Diseases
CFDA Code
846
DUNS Number
192972136
UEI
Project Start Date
10-August-2006
Project End Date
31-January-2008
Budget Start Date
10-August-2006
Budget End Date
31-January-2008
Project Funding Information for 2006
Total Funding
$111,482
Direct Costs
$99,751
Indirect Costs
$7,443
Year
Funding IC
FY Total Cost by IC
2006
National Institute of Arthritis and Musculoskeletal and Skin Diseases
$111,482
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 1R41AR053407-01
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1R41AR053407-01
Patents
No Patents information available for 1R41AR053407-01
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1R41AR053407-01
Clinical Studies
No Clinical Studies information available for 1R41AR053407-01
News and More
Related News Releases
No news release information available for 1R41AR053407-01
History
No Historical information available for 1R41AR053407-01
Similar Projects
No Similar Projects information available for 1R41AR053407-01